Download PDF
Semin Reprod Med 2010; 28(3): 228-234
DOI: 10.1055/s-0030-1251479
© Thieme Medical Publishers

Minimally Invasive Approach for Myomectomy

Mohammed Agdi1 , Togas Tulandi1
  • 1Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada
Further Information

Publication History

Publication Date:
22 April 2010 (online)

    Permissions and Reprints

ABSTRACT

Uterine fibroids are the most common benign tumor of the uterus in women of reproductive age. However, most of them are asymptomatic and do not require any treatment. Menorrhagia and pelvic pain are the most usual symptoms, and some women may present with infertility or pregnancy-related complications. In those with abnormal uterine bleeding, one should exclude other causes of abnormal vaginal bleeding including endometrial cancer. Diagnosis of uterine fibroid is established by pelvic ultrasonography with or without saline infusion hysterosonography. Management options depend on the patient's fertility potential and desire for future pregnancy. Submucous myoma should be treated by a hysteroscopic approach. Intramural and subserous myomas in women who opt for nonsurgical treatment could be treated with uterine artery embolization (UAE), high-intensity focused ultrasound (HIFU), or medical treatment such as selective gonadotropin-releasing hormone agonists, progesterone receptor modulators, or aromatase inhibitors. All interventions aside from hysterectomy provide temporary relief, although myomectomy, UAE, and HIFU provides more durable symptom relief relative to current medical management. Patients wishing to preserve their fertility are best treated by myomectomy, which can be done by laparoscopy. A laparoscopic approach is more advantageous than laparotomy, but laparoscopic suturing is more demanding. This can be overcome by robotic-assisted laparoscopic myomectomy.

KEYWORDS

Laparoscopy - laparoscopic myomectomy - hysteroscopy - hysteroscopic myomectomy - robotic-assisted myomectomy

REFERENCES

  • 1 Day Baird D, Dunson D B, Hill M C, Cousins D, Schectman J M. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.  Am J Obstet Gynecol. 2003;  188(1) 100-107
    CrossrefPubMedGoogle Scholar
  • 2 Haney A F. Clinical decision making regarding leiomyomata: what we need in the next millennium.  Environ Health Perspect. 2000;  108(suppl 5) 835-839
    CrossrefPubMedGoogle Scholar
  • 3 Nowak R A. Fibroids: pathophysiology and current medical treatment.  Baillieres Best Pract Res Clin Obstet Gynaecol. 1999;  13(2) 223-238
    CrossrefPubMedGoogle Scholar
  • 4 Marino J L, Eskenazi B, Warner M et al.. Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study.  Hum Reprod. 2004;  19(10) 2350-2355
    CrossrefPubMedGoogle Scholar
  • 5 Buttram Jr V C. Uterine leiomyomata—aetiology, symptomatology and management.  Prog Clin Biol Res. 1986;  225 275-296
    PubMedGoogle Scholar
  • 6 Seracchioli R, Rossi S, Govoni F et al.. Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy.  Hum Reprod. 2000;  15(12) 2663-2668
    CrossrefPubMedGoogle Scholar
  • 7 Jourdain O, Descamps P, Abusada N et al.. Treatment of fibromas.  Eur J Obstet Gynecol Reprod Biol. 1996;  66(2) 99-107
    CrossrefPubMedGoogle Scholar
  • 8 de Kroon C D, de Bock G H, Dieben S W, Jansen F W. Saline contrast hysterosonography in abnormal uterine bleeding: a systematic review and meta-analysis.  BJOG. 2003;  110(10) 938-947
    PubMedGoogle Scholar
  • 9 Brooks P G. In the management of abnormal uterine bleeding, is office hysteroscopy preferable to sonography? The case for hysteroscopy.  J Minim Invasive Gynecol. 2007;  14(1) 12-14
    CrossrefPubMedGoogle Scholar
  • 10 Imai A, Sugiyama M, Furui T, Tamaya T. Treatment of perimenopausal women with uterine myoma: successful use of a depot GnRH agonist leading to a natural menopause.  J Obstet Gynaecol. 2003;  23(5) 518-520
    CrossrefPubMedGoogle Scholar
  • 11 Huang J Y, Kafy S, Dugas A, Valenti D, Tulandi T. Failure of uterine fibroid embolization.  Fertil Steril. 2006;  85(1) 30-35
    CrossrefPubMedGoogle Scholar
  • 12 Reinblatt S L, Krishnamurthy S, Valenti D, Tulandi T. Septic uterus after uterine artery embolization for uterine myomas triggered by endometrial biopsy.  J Obstet Gynaecol Can. 2008;  30(4) 344-346
    PubMedGoogle Scholar
  • 13 Agdi M, Valenti D, Tulandi T. Intraabdominal adhesions after uterine artery embolization.  Am J Obstet Gynecol. 2008;  199(5) 482.e481-483
    PubMedGoogle Scholar
  • 14 Mais V, Ajossa S, Guerriero S, Mascia M, Solla E, Melis G B. Laparoscopic versus abdominal myomectomy: a prospective, randomized trial to evaluate benefits in early outcome.  Am J Obstet Gynecol. 1996;  174(2) 654-658
    CrossrefPubMedGoogle Scholar
  • 15 Palomba S, Zupi E, Russo T et al.. A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: short-term outcomes.  Fertil Steril. 2007;  88(4) 942-951
    CrossrefPubMedGoogle Scholar
  • 16 Rossetti A, Sizzi O, Soranna L, Cucinelli F, Mancuso S, Lanzone A. Long-term results of laparoscopic myomectomy: recurrence rate in comparison with abdominal myomectomy.  Hum Reprod. 2001;  16(4) 770-774
    CrossrefPubMedGoogle Scholar
  • 17 Marret H, Chevillot M, Giraudeau B. Study Group of the French Society of Gynaecology and Obstetrics (Ouest Division) . Factors influencing laparoconversions during the learning curve of laparoscopic myomectomy.  Acta Obstet Gynecol Scand. 2006;  85(3) 324-329
    CrossrefPubMedGoogle Scholar
  • 18 Dubuisson J B, Fauconnier A, Fourchotte V, Babaki-Fard K, Coste J, Chapron C. Laparoscopic myomectomy: predicting the risk of conversion to an open procedure.  Hum Reprod. 2001;  16(8) 1726-1731
    CrossrefPubMedGoogle Scholar
  • 19 Tulandi T, Béique F, Kimia M. Pulmonary edema: a complication of local injection of vasopressin at laparoscopy.  Fertil Steril. 1996;  66(3) 478-480
    PubMedGoogle Scholar
  • 20 Martin J D, Shenk L G. Intraoperative myocardial infarction after paracervical vasopressin infiltration.  Anesth Analg. 1994;  79(6) 1201-1202
    PubMedGoogle Scholar
  • 21 Zullo F, Palomba S, Corea D et al.. Bupivacaine plus epinephrine for laparoscopic myomectomy: a randomized placebo-controlled trial.  Obstet Gynecol. 2004;  104(2) 243-249
    CrossrefPubMedGoogle Scholar
  • 22 Alborzi S, Ghannadan E, Alborzi S, Alborzi M. A comparison of combined laparoscopic uterine artery ligation and myomectomy versus laparoscopic myomectomy in treatment of symptomatic myoma.  Fertil Steril. 2009;  92(2) 742-747
    CrossrefPubMedGoogle Scholar
  • 23 Discepola F, Valenti D A, Reinhold C, Tulandi T. Analysis of arterial blood vessels surrounding the myoma: relevance to myomectomy.  Obstet Gynecol. 2007;  110(6) 1301-1303
    CrossrefPubMedGoogle Scholar
  • 24 Agdi M, Tulandi T. The benefits of intrauterine balloon: an intrauterine manipulator and balloon proved useful in myomectomy.  Am J Obstet Gynecol. 2008;  199(5) 581.e1
    PubMedGoogle Scholar
  • 25 Sinha R, Hegde A, Warty N, Mahajan C. Laparoscopic myomectomy: enucleation of the myoma by morcellation while it is attached to the uterus.  J Minim Invasive Gynecol. 2005;  12(3) 284-289
    CrossrefPubMedGoogle Scholar
  • 26 Takeuchi H, Kitade M, Kikuchi I, Shimanuki H, Kumakiri J, Takeda S. Influencing factors of adhesion development and the efficacy of adhesion-preventing agents in patients undergoing laparoscopic myomectomy as evaluated by a second-look laparoscopy.  Fertil Steril. 2008;  89(5) 1247-1253
    CrossrefPubMedGoogle Scholar
  • 27 Tsuji S, Takahashi K, Yomo H et al.. Effectiveness of antiadhesion barriers in preventing adhesion after myomectomy in patients with uterine leiomyoma.  Eur J Obstet Gynecol Reprod Biol. 2005;  123(2) 244-248
    CrossrefPubMedGoogle Scholar
  • 28 Takeuchi H, Kitade M, Kikuchi I, Shimanuki H, Kumakiri J, Kinoshita K. Adhesion-prevention effects of fibrin sealants after laparoscopic myomectomy as determined by second-look laparoscopy: a prospective, randomized, controlled study.  J Reprod Med. 2005;  50(8) 571-577
    PubMedGoogle Scholar
  • 29 Mais V, Ajossa S, Piras B, Guerriero S, Marongiu D, Melis G B. Prevention of de-novo adhesion formation after laparoscopic myomectomy: a randomized trial to evaluate the effectiveness of an oxidized regenerated cellulose absorbable barrier.  Hum Reprod. 1995;  10(12) 3133-3135
    PubMedGoogle Scholar
  • 30 Yoo E H, Lee P I, Huh C Y et al.. Predictors of leiomyoma recurrence after laparoscopic myomectomy.  J Minim Invasive Gynecol. 2007;  14(6) 690-697
    CrossrefPubMedGoogle Scholar
  • 31 Sizzi O, Rossetti A, Malzoni M et al.. Italian multicenter study on complications of laparoscopic myomectomy.  J Minim Invasive Gynecol. 2007;  14(4) 453-462
    CrossrefPubMedGoogle Scholar
  • 32 Kumakiri J, Takeuchi H, Itoh S et al.. Prospective evaluation for the feasibility and safety of vaginal birth after laparoscopic myomectomy.  J Minim Invasive Gynecol. 2008;  15(4) 420-424
    CrossrefPubMedGoogle Scholar
  • 33 Hurst B S, Matthews M L, Marshburn P B. Laparoscopic myomectomy for symptomatic uterine myomas.  Fertil Steril. 2005;  83(1) 1-23
    CrossrefPubMedGoogle Scholar
  • 34 Advincula A P, Song A. Endoscopic management of leiomyomata.  Semin Reprod Med. 2004;  22(2) 149-155
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Advincula A P, Song A, Burke W, Reynolds R K. Preliminary experience with robot-assisted laparoscopic myomectomy.  J Am Assoc Gynecol Laparosc. 2004;  11(4) 511-518
    CrossrefPubMedGoogle Scholar
  • 36 Advincula A P, Song A. The role of robotic surgery in gynecology.  Curr Opin Obstet Gynecol. 2007;  19(4) 331-336
    CrossrefPubMedGoogle Scholar
  • 37 Advincula A P, Xu X, Goudeau IV St, Ransom S B. Robot-assisted laparoscopic myomectomy versus abdominal myomectomy: a comparison of short-term surgical outcomes and immediate costs.  J Minim Invasive Gynecol. 2007;  14(6) 698-705
    CrossrefPubMedGoogle Scholar
  • 38 Nezhat C, Lavie O, Hsu S, Watson J, Barnett O, Lemyre M. Robotic-assisted laparoscopic myomectomy compared with standard laparoscopic myomectomy—a retrospective matched control study.  Fertil Steril. 2009;  91(2) 556-559
    CrossrefPubMedGoogle Scholar
  • 39 Ben-Baruch G, Schiff E, Menashe Y, Menczer J. Immediate and late outcome of vaginal myomectomy for prolapsed pedunculated submucous myoma.  Obstet Gynecol. 1988;  72(6) 858-861
    PubMedGoogle Scholar
  • 40 Wamsteker K, Emanuel M H, de Kruif J H. Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: results regarding the degree of intramural extension.  Obstet Gynecol. 1993;  82(5) 736-740
    PubMedGoogle Scholar
  • 41 Varasteh N N, Neuwirth R S, Levin B, Keltz M D. Pregnancy rates after hysteroscopic polypectomy and myomectomy in infertile women.  Obstet Gynecol. 1999;  94(2) 168-171
    CrossrefPubMedGoogle Scholar
  • 42 Hart R, Molnár B G, Magos A. Long term follow up of hysteroscopic myomectomy assessed by survival analysis.  Br J Obstet Gynaecol. 1999;  106(7) 700-705
    PubMedGoogle Scholar
  • 43 Varma R, Soneja H, Clark T J, Gupta J K. Hysteroscopic myomectomy for menorrhagia using Versascope bipolar system: efficacy and prognostic factors at a minimum of one year follow up.  Eur J Obstet Gynecol Reprod Biol. 2009;  142(2) 154-159
    PubMedGoogle Scholar
  • 44 Murphy A A, Kettel L M, Morales A J, Roberts V J, Yen S S. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.  J Clin Endocrinol Metab. 1993;  76(2) 513-517
    CrossrefPubMedGoogle Scholar
  • 45 Murphy A A, Morales A J, Kettel L M, Yen S S. Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect.  Fertil Steril. 1995;  64(1) 187-190
    PubMedGoogle Scholar
  • 46 Zeng C, Gu M, Huang H. A clinical control study on the treatment of uterine leiomyoma with gonadotrophin releasing hormone agonist or mifepristone [in Chinese].  Zhonghua Fu Chan Ke Za Zhi. 1998;  33(8) 490-492
    PubMedGoogle Scholar
  • 47 Eisinger S H, Meldrum S, Fiscella K, le Roux H D, Guzick D S. Low-dose mifepristone for uterine leiomyomata.  Obstet Gynecol. 2003;  101(2) 243-250
    CrossrefPubMedGoogle Scholar
  • 48 Pintiaux A, Chabbert-Buffet N, Foidart J M. Gynaecological uses of a new class of steroids: the selective progesterone receptor modulators.  Gynecol Endocrinol. 2009;  25(2) 67-73
    CrossrefPubMedGoogle Scholar
  • 49 Ohara N. Action of progesterone receptor modulators on uterine leiomyomas.  Clin Exp Obstet Gynecol. 2008;  35(3) 165-166
    PubMedGoogle Scholar
  • 50 Spitz I M. Progesterone antagonists and progesterone receptor modulators.  Expert Opin Investig Drugs. 2003;  12(10) 1693-1707
    CrossrefPubMedGoogle Scholar
  • 51 Olive D L. Role of progesterone antagonists and new selective progesterone receptor modulators in reproductive health.  Obstet Gynecol Surv. 2002;  57(11, suppl 4) S55-S63
    CrossrefPubMedGoogle Scholar
  • 52 Chwalisz K, Brenner R M, Fuhrmann U U, Hess-Stumpp H, Elger W. Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium.  Steroids. 2000;  65(10–11) 741-751
    CrossrefPubMedGoogle Scholar
  • 53 Palomba S, Orio Jr F, Morelli M et al.. Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study.  J Clin Endocrinol Metab. 2002;  87(8) 3603-3608
    CrossrefPubMedGoogle Scholar
  • 54 Parsanezhad M E, Azmoon M, Alborzi S et al.. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.  Fertil Steril. 2010;  93(1) 192-198
    CrossrefPubMedGoogle Scholar
  • 55 Hilário S G, Bozzini N, Borsari R, Baracat E C. Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients.  Fertil Steril. 2009;  91(1) 240-243
    CrossrefPubMedGoogle Scholar
  • 56 Stewart E A, Rabinovici J, Tempany C M et al.. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids.  Fertil Steril. 2006;  85(1) 22-29
    CrossrefPubMedGoogle Scholar
  • 57 Stewart E A, Gostout B, Rabinovici J, Kim H S, Regan L, Tempany C M. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery.  Obstet Gynecol. 2007;  110(2 Pt 1) 279-287
    CrossrefPubMedGoogle Scholar
  • 58 Rabinovici J, David M, Fukunishi H et al.. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids.  Fertil Steril. 2010;  93(1) 199-209
    CrossrefPubMedGoogle Scholar

Togas TulandiM.D. M.H.C.M. 

687 Pine Ave. West, Montreal, Quebec

Canada, H3A 1A1

Email: togas.tulandi@mcgill.ca

      >